![]() |
Volumn 39, Issue 17, 1996, Pages 3235-3237
|
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB- 1508Y): A novel anti-Parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE;
ANTIPARKINSON AGENT;
DIHYDRO BETA ERYTHROIDINE;
DOPAMINE;
MECAMYLAMINE;
MUSCARINIC RECEPTOR;
NICOTINE;
NICOTINIC RECEPTOR;
QUINUCLIDINYL BENZILATE;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CORPUS STRIATUM;
DOPAMINE RELEASE;
DRUG ANTAGONISM;
DRUG DISCRIMINATION;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
NONHUMAN;
PARKINSON DISEASE;
RAT;
RECEPTOR AFFINITY;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTIPARKINSON AGENTS;
CELL LINE;
FEMALE;
HUMANS;
KINETICS;
MOLECULAR STRUCTURE;
NEURONS;
OOCYTES;
PATCH-CLAMP TECHNIQUES;
PYRIDINES;
PYRROLIDINES;
RECEPTORS, NICOTINIC;
RECOMBINANT PROTEINS;
STEREOISOMERISM;
XENOPUS;
|
EID: 0029784854
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm960328w Document Type: Article |
Times cited : (110)
|
References (0)
|